MCL1 and type 1 diabetes mellitus: Moreover, by targeting the antiapoptotic protein myeloid cell leukemia-1 (Mcl1), it promoted β-cell apoptosis and therefore pancreatic dysfunction in the early stages of T1DM development [48].